| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.83B | 4.65B | 4.26B | 3.86B | 2.93B |
| Gross Profit | 137.91M | 1.81B | 1.57B | 829.30M | 2.90B |
| EBITDA | 712.20M | 849.80M | 656.30M | 896.70M | 863.60M |
| Net Income | 120.22M | 127.50M | -15.90M | 87.10M | 636.40M |
Balance Sheet | |||||
| Total Assets | 3.10B | 3.66B | 3.81B | 4.41B | 3.83B |
| Cash, Cash Equivalents and Short-Term Investments | 432.02M | 171.40M | 496.50M | 791.40M | 787.70M |
| Total Debt | 1.16B | 1.35B | 1.63B | 2.07B | 1.41B |
| Total Liabilities | 2.38B | 2.95B | 3.17B | 3.66B | 2.95B |
| Stockholders Equity | 710.04M | 696.70M | 633.30M | 740.20M | 876.60M |
Cash Flow | |||||
| Free Cash Flow | 384.86M | 597.80M | 324.00M | 395.90M | -186.20M |
| Operating Cash Flow | 630.59M | 754.20M | 543.30M | 573.80M | 65.40M |
| Investing Cash Flow | -194.21M | -150.90M | -10.20M | 79.40M | 2.08B |
| Financing Cash Flow | -460.88M | -641.50M | -776.30M | -640.90M | -2.89B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $46.46B | 38.47 | 10.94% | 0.46% | 9.59% | 10.69% | |
67 Neutral | $450.66M | 39.39 | 6.39% | ― | 11.73% | -68.10% | |
65 Neutral | $1.36B | 8.29 | 19.28% | 3.02% | -1.44% | 5.88% | |
64 Neutral | $1.54B | 10.52 | 9.51% | 2.71% | -17.66% | -26.36% | |
64 Neutral | $2.74B | 10.77 | 24.50% | 4.34% | -27.72% | 91.42% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | $178.36M | 10.18 | -33.78% | ― | -4.92% | ― |